Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001104659-25-057322·MOULDER LEON O JR
Schedule 13D ownership disclosure
Zenas Biopharma Inc
Common Stock, $0.0001 par value per share · CUSIP: 98937L105
Event date: 2025-05-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Leon O. Moulder, Jr.Reported CIK 0001228865
Shares: 2,098,646.00 · Class: 5.0%
- Tellus BioVentures, LLC
Shares: 1,672,039.00 · Class: 4.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-057322
- Form type
- SCHEDULE 13D
- Filer
- MOULDER LEON O JR
- CIK
- CIK 1228865
- Filed
- Jun 06, 2025
- Reporting period
- May 30, 2025
- Description
- Schedule 13D beneficial ownership